0001062993-15-003576.txt : 20150625 0001062993-15-003576.hdr.sgml : 20150625 20150625170252 ACCESSION NUMBER: 0001062993-15-003576 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150623 FILED AS OF DATE: 20150625 DATE AS OF CHANGE: 20150625 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gitman Paul CENTRAL INDEX KEY: 0001375378 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 15952381 MAIL ADDRESS: STREET 1: 167 EXECUTIVE DRIVE CITY: MANHASSET HILLS STATE: NY ZIP: 11040 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2015-06-23 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001375378 Gitman Paul C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 WILBUR STREET LYNBROOK NY 11563 1 0 0 0 Common Stock, $0.001 par value 2015-06-23 4 M 0 6308 13.60 A 58133 D Common Stock, $0.001 par value 2015-06-23 4 M 0 15000 26.43 A 73133 D Common Stock, $0.001 par value 2015-06-23 4 M 0 15000 20 A 88133 D Common Stock, $0.001 par value 2015-06-23 4 S 0 6308 53.5856 D 81825 D Common Stock, $0.001 par value 2015-06-23 4 S 0 15000 51.8390 D 66825 D Common Stock, $0.001 par value 2015-06-23 4 S 0 15000 50.9540 D 51825 D Stock Option (Right to Buy) 13.60 2015-06-23 4 M 0 6308 0 D 2018-06-09 Common Stock, $0.001 par value 6308 8692 D Stock Option (Right to Buy) 26.43 2015-06-23 4 M 0 15000 0 D 2019-09-07 Common Stock, $0.001 par value 15000 0 D Stock Option (Right to Buy) 20.00 2015-06-23 4 M 0 15000 0 D 2018-09-07 Common Stock, $0.001 par value 15000 0 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2015. The selling price of $53.5856 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $53.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The selling price of $51.8390 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $51.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The selling price of $50.9540 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The option was granted on June 10, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested. The option was granted on September 8, 2009 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested. The option was granted on September 8, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested. /s/ Carl A. Valenstein, attorney-in-fact for Paul Gitman 2015-06-25